MET (MetLife) ROCE %: % (As of Mar. 2026)


MET MetLife Inc MET
76 GF Score
Price $84.60
GF Value $89.60
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is MetLife ROCE %?

MetLife MET -3.90% 76 ROCE % is % as of Mar. 2026. GuruFocus rates MET with a GF Score™ of 76/100 and a GF Value™ of $89.60 (Fairly Valued). The stock has 8 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

MET
76GF Score
MetLife Inc MET
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
MetLife (MET) has a ROCE % of % as of Mar. 2026.
Is MetLife's ROCE % too high?
MetLife's current ROCE % is %. Overall, MetLife has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MetLife's ROCE % compare to AFL and PRU?
MetLife's ROCE % of % can be compared against companies in the Insurance industry. The industry median ROCE % is 8.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Insurance company?
The median ROCE % among Insurance companies is 8.53, based on 63 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Insurance industry, the median ROCE % is 8.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MetLife's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetLife stock overvalued right now?
Based on GuruFocus' analysis, MetLife (MET) is currently considered Fairly Valued. The stock's GF Value™ is $89.60, compared to a current price of $84.60 — trading 5.6% below its estimated fair value. The current ROCE % is %. MetLife's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For MetLife (MET), the current ROCE % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MetLife (MET) Overvalued in 2026?

Based on GuruFocus' analysis, MetLife stock appears to be undervalued. The current stock price of $84.60 is trading 5.6% below its estimated GF Value™ of $89.60. GuruFocus considers MetLife to be Fairly Valued.

Key valuation signals for MET:

  • ROCE %: %
  • GF Value™: $89.60 vs. price of $84.60 (5.6% below fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the MET stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MetLife Business Description

Address 200 Park Avenue, New York, NY, USA, 10166-0188
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
76GF Score

Get the complete analysis for MET

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$84.60
Price
$89.60
GF Value